Watch as Dr David Bunka, Aptamer Group CTO, details how BLI is used within Aptamer Group’s screening and validation processes to identify the best aptamer and Optimer™ reagents, with…
Proteins can undergo post-translational modification (PTM) of their amino acids which can lead to a change in their activity and increase their functional repertoire. The most common of these…
Prostate cancer is the most common cancer among men, with approximately 1.1 million new cases diagnosed per year worldwide. Most cancer-related deaths are caused by metastases in vital organs,…
Benefits of Aptamers for Protein Applications Proteins play significant roles in the physiological and pathological mechanisms of living organisms including human beings. There is an increased demand for convenient methodologies…
23rd May 2017 AptaBasics: Aptamer Selection At Aptamer Group we can select and identify novel aptamers to specific targets in as little as 12 weeks. To select…
